CNSX:IME - Imagin Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$0.30 +0.01 (+3.45 %)
(As of 07/23/2018 11:24 AM ET)
Previous CloseC$0.29
Today's RangeC$0.28 - C$0.30
52-Week RangeC$0.05 - C$0.44
Volume1.27 million shs
Average VolumeN/A
Market CapitalizationC$24.80 million
P/E RatioN/A
Dividend YieldN/A
Imagin Medical Inc is a Canada-based medical imaging company. The Company is engaged in the development of i/Blue imaging system for the early detection of cancer through the use of endoscopes. The Company focuses on managing the way physicians detect cancer. The Company's initial target market is bladder cancer. The Company's imaging technology is based upon optical designs and advanced light sensors. The Company develops Prototype Alpha B, a combination of optical/light sensor technology, white light and near-infrared fluorescence that is estimated to be more sensitive than current systems with the ability to expose the specifics of the image. The i/Blue's cameras employ Simultaneous Acquisition of Differing Images, a patented technology, which blends the white and blue light images into one, putting cancer into context and enabling surgeons to visualize and resect cancer.

Receive IME News and Ratings via Email

Sign-up to receive the latest news and ratings for IME and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange CNSX
Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity-801.95%
Return on Assets-427.60%


Outstanding Shares50,070,000
Market CapC$24.80

Imagin Medical (CNSX:IME) Frequently Asked Questions

What is Imagin Medical's stock symbol?

Imagin Medical trades on the CNSX under the ticker symbol "IME."

What is the consensus analysts' recommendation for Imagin Medical?

0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Imagin Medical in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A."

Who are Imagin Medical's key executives?

Imagin Medical's management team includes the folowing people:
  • E. James Hutchens, President, Chief Executive Officer, Director
  • Jorge Avelino, Chief Financial Officer
  • Thom McMahon, Director of Sales
  • Stephen Ruggles, Director of Quality Assurance and Regulatory Affairs
  • Michael G. Vergano, Director of Operations
  • William Galine, Corporate Secretary, Director
  • Robin A. Atlas, Independent Director
  • Steven J. Chan, Independent Director (Age 51)
  • Ken Daignault, Independent Director

Has Imagin Medical been receiving favorable news coverage?

News articles about IME stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Imagin Medical earned a media sentiment score of 0.14 on Accern's scale. They also assigned news headlines about the company an impact score of 45.86 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.

What is Imagin Medical's stock price today?

One share of IME stock can currently be purchased for approximately C$0.30.

How big of a company is Imagin Medical?

Imagin Medical has a market capitalization of C$24.80 million.

How can I contact Imagin Medical?

Imagin Medical's mailing address is 890 Pender St W Suite 600, VANCOUVER, BC V6C 1J9, Canada. The company can be reached via phone at +1-604-6623903.

MarketBeat Community Rating for Imagin Medical (CNSX IME)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  26 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  50
MarketBeat's community ratings are surveys of what our community members think about Imagin Medical and other stocks. Vote "Outperform" if you believe IME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IME will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.